BioNTech SE (BNTX)
100.60
+1.85
(+1.87%)
USD |
NASDAQ |
May 31, 16:00
100.51
-0.09
(-0.09%)
After-Hours: 20:00
BioNTech Free Cash Flow: 5.344B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.344B |
| December 31, 2023 | 5.051B |
| September 30, 2023 | 5.675B |
| June 30, 2023 | 9.240B |
| March 31, 2023 | 8.673B |
| December 31, 2022 | 13.94B |
| September 30, 2022 | 12.33B |
| June 30, 2022 | 9.782B |
| March 31, 2022 | 5.757B |
| Date | Value |
|---|---|
| December 31, 2021 | 870.47M |
| September 30, 2021 | 1.414B |
| June 30, 2021 | -574.96M |
| March 31, 2021 | -453.62M |
| December 31, 2020 | -112.95M |
| September 30, 2020 | -444.24M |
| June 30, 2020 | -265.82M |
| March 31, 2020 | -297.70M |
| December 31, 2019 | -301.82M |
Free Cash Flow Range, Past 5 Years
-574.96M
Minimum
Jun 2021
13.94B
Maximum
Dec 2022
4.201B
Average
3.232B
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 5.106B |
| Moderna Inc | -3.672B |
| GSK PLC | 6.584B |
| NuCana PLC | -28.30M |
| Autolus Therapeutics PLC | -151.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -344.65M |
| Cash from Investing (Quarterly) | -2.503B |
| Cash from Financing (Quarterly) | -8.472M |
| Free Cash Flow Per Share (Quarterly) | -2.051 |
| Free Cash Flow to Equity (Quarterly) | -506.34M |
| Free Cash Flow to Firm (Quarterly) | -493.35M |
| Free Cash Flow Yield | 22.10% |